Page last updated: 2024-09-04

cvt 124 and furosemide

cvt 124 has been researched along with furosemide in 5 studies

Compound Research Comparison

Studies
(cvt 124)
Trials
(cvt 124)
Recent Studies (post-2010)
(cvt 124)
Studies
(furosemide)
Trials
(furosemide)
Recent Studies (post-2010) (furosemide)
182013,6311,3582,486

Protein Interaction Comparison

ProteinTaxonomycvt 124 (IC50)furosemide (IC50)
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)3.76
Corticosteroid 11-beta-dehydrogenase isozyme 1Mus musculus (house mouse)3.76
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)3.2

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brooks, DP; DeWolf, R; Fletcher, T; Gellai, M; Ruffolo, RR; Schreiner, GF1
Beckman, E; Bennett, D; Cines, M; Fisher, ML; Freudenberger, R; Gladwell, T; Gottlieb, SS; Liittschwager, EB; Marshall, J; Skettino, SL; Wolff, A1
Herzer, WA; Jackson, EK; Kost, CK; Smits, GJ; Tofovic, SP1
Abraham, WT; Beckman, E; Bennett, D; Bourge, R; Brater, DC; Dyer, F; Goldman, S; Gomez, M; Gottlieb, SS; Havranek, E; Thomas, I; Ticho, B1
Gottlieb, SS1

Reviews

1 review(s) available for cvt 124 and furosemide

ArticleYear
Adenosine A1 antagonists and the cardiorenal syndrome.
    Current heart failure reports, 2008, Volume: 5, Issue:2

    Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Kidney Function Tests; Male; Mice; Prognosis; Randomized Controlled Trials as Topic; Receptor, Adenosine A1; Risk Assessment; Severity of Illness Index; Syndrome; Treatment Outcome; Xanthines

2008

Trials

2 trial(s) available for cvt 124 and furosemide

ArticleYear
Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
    Journal of the American College of Cardiology, 2000, Volume: 35, Issue:1

    Topics: Adult; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged; Natriuresis; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Water-Electrolyte Balance; Xanthines

2000
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
    Circulation, 2002, Mar-19, Volume: 105, Issue:11

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diuresis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Purinergic P1 Receptor Antagonists; Sodium; Urinalysis; Xanthines

2002

Other Studies

2 other study(ies) available for cvt 124 and furosemide

ArticleYear
CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:3

    Topics: Animals; Diuretics; Dose-Response Relationship, Drug; Furosemide; Glomerular Filtration Rate; Hydrochlorothiazide; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Renal Circulation; Xanthines

1998
A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemide.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 299, Issue:3

    Topics: Animals; Furosemide; Hemodynamics; Hypertension; Kidney Function Tests; Metabolic Clearance Rate; Natriuresis; Purinergic P1 Receptor Antagonists; Rats; Sodium Chloride; Xanthines

2001